Pediatric Hematology and Oncology at Seattle Children's Hospital
Pediatric Hematology & Oncology
Dr. Phoenix A. Ho, MD
|
|
Give Review
Phoenix A. Ho, MD practices Pediatric Hematology & Oncology. He went to medical school at Northeast Ohio Medical University. Phoenix A. Ho is a published physician. He published 15 publications, including: 'Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia.'
Publications
- Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD Acute myeloid leukemia.
- High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric Acute myeloid leukaemia: a report from the children's oncology...
- The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: Report from the Children's Oncology Group.
- Mutations in the DNMT3A exon 23 independently predict poor outcome in older patients with Acute myeloid leukemia: a SWOG report.
- Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric/adult AML: a report from the Children's Oncology Group and SWOG.
- Prevalence and clinical implications of NRAS mutations in childhood AML: a report from the Children's Oncology Group.
- Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group.
- WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric ac...
- C/EBPα regulated microRNA-34a targets E2F3 during granulopoiesis and is down-regulated in AML with CEBPA mutations.
- Prevalence and prognostic implications of WT1 mutations in pediatric Acute myeloid leukemia (AML): a report from the Children's Oncology Group.
- High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric Acute myeloid leukemia: a report f...
- Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.
- Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo ...
- Prevalence and prognostic implications of CEBPA mutations in pediatric Acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Schools
Northeastern Ohio University College of Medicine
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anemia
- Bladder Cancer
- View All
Doctors Specialties
- Pediatric Hematology
- Oncology
Accepted Insurances
Education
-
Yale-New Haven Hospital -
Northeast Ohio Medical University
Hospital
-
Seattle Children's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Jenny W. Pang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Colleen S. Delaney, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Ann E. Dahlberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric J. Chow, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Rebecca A. Gardner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dana C. Matthews, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Barbara E. Small, MD |
|
|
Dr. Douglas S. Hawkins, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Ronald S. Cheung, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tracy A. Hentz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher T. Lux, MD
This Doctor is OpenDoctor Recommended.
|